b2l - Transplant News

Bridge to Life CEO Don Webber Shares HOPE Breakthrough with Transplant Community at WTC 2025

Bridge to Life CEO Don Webber Shares HOPE Breakthrough with Transplant Community at WTC 2025 To the Organ Transplantation Community, What an incredible week it was for Bridge to Life at the World

New Data Analyses from Groundbreaking Pivotal Bridge to HOPE Clinical Trial Demonstrate Statistically Significant Clinical, Economic and Immunomodulatory Advantages in Liver Transplantation

FOR IMMEDIATE RELEASE New Data Analyses from Groundbreaking Pivotal Bridge to HOPE Clinical Trial Demonstrate Statistically Significant Clinical, Economic and Immunomodulatory Advantages in Liver Transplantation Presentations showcased at World Transplant Congress in

First-Ever Comparative Study of Hypothermic Oxygenated Machine Perfusion (HOPE) with Normothermic Machine Perfusion (NMP) in Liver Transplantation Shows Better Outcomes With HOPE

FOR IMMEDIATE RELEASE First-Ever Comparative Study of Hypothermic Oxygenated Machine Perfusion (HOPE) with Normothermic Machine Perfusion (NMP) in Liver Transplantation Shows Better Outcomes With HOPE New data presented during Plenary Session at

Bridge to Life™ Unveils Groundbreaking 12-Month Clinical Trial Data on HOPE at World Transplant Congress 2025

FOR IMMEDIATE RELEASE Bridge to Life™ Unveils Groundbreaking 12-Month Clinical Trial Data on HOPE at World Transplant Congress 2025 Pivotal Findings Spotlighted in Plenary Session, Late-Breaking Presentations, and Symposium on Next-Gen Liver

Bridge to Life Announces Abstract Presentations at The 2025 International Congress of the International Liver Transplantation Society (ILTS) in Singapore, May 28-31, 2025

Abstracts to highlight hypothermic oxygenated perfusion (HOPE) in liver transplants, including pediatric patients Chicago, May 15, 2025 Bridge to Life™ Ltd., a leader in organ preservation solutions and perfusion technology, today announced the

Bridge to Life Acquires VitaSmart™ Hypothermic Oxygenated Machine Perfusion System from Medica S.p.A.

Ownership Strengthens Bridge to Life's Position in Organ Preservation and Solidifies Enterprise Value Chicago, December 18, 2024 – Bridge to Life Ltd., a leader in organ preservation solutions and perfusion technology, has

Bridge to Life Ltd. Achieves Global Milestone in Liver Transplants Using Hypothermic Oxygenated Perfusion (HOPE) and VitaSmart™ System

Chicago, November 14, 2024 – Bridge to Life Ltd., a leading provider of organ preservation solutions and organ perfusion equipment, has announced that more than 5,0001 liver perfusions worldwide have

Italian Study Demonstrates Higher Utilization of Marginal Organs and Greater Transplantation Success in Patients at Higher Risk

At the 2024 ELITA Summit, an Italian study showcased remarkable advancements in liver transplantation, challenging long-standing perceptions of marginal donor organs. Led by Dr. Matteo Ravaioli and his team from

Two Independent Studies Representing Largest Real-World Experience with Hypothermic Oxygenated Machine Perfusion (HOPE) Reinforce Significant Benefits in Liver Preservation Before Transplantation, according to Bridge to Life Ltd.

Portuguese study confirms use of HOPE provides demonstrably improved liver graft utilization with reduced rates of non-anastomotic biliary stricture (NAS); Italian study demonstrates increasing experience in managing DCD (donation after